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Abstract 
Introduction. A number of studies highlight the difficulty in forming a diagnosis for patients 
with disorders of consciousness when this is established merely on behavioral assessments. 
Background. Positron emission tomography (PET), functional magnetic resonance im-
aging (fMRI), diffusion tensor imaging (DTI), and electroencephalography combined 
with transcranial magnetic stimulation (TMS-EEG) techniques are promoting the clini-
cal characterization of this challenging population. With such technology-based “objec-
tive” tools, patients are also differentially able to follow simple commands and in some 
cases even communicate through modified brain activity. Consequently, the vegetative 
state and minimally conscious state have been revised and new nosologies have been pro-
posed, namely the unresponsive wakefulness syndrome, the minimally conscious state 
plus and minus, and the functional locked-in syndrome. 
Aim. To our mind, an integration of different technical modalities is important to gain a 
holistic vision of the underlying pathophysiology of disorders of consciousness in general 
and to promote single-patient medical management in particular.
IntroDuCtIon
Disorders of consciousness (DOC) are among the 
most challenging and poorly understood conditions of 
modern medical care. These clinical conditions have 
increasingly appeared in the clinical setting since emer-
gency medicine and lifesaving technologies had been 
introduced back in the 1950s [1]. Ever since, the ad-
vance of such tools contributed to the raising number 
of patients who survived after sustaining extreme brain 
damage. At the same time, the introduction of medical 
imaging in the 1970s, and its rapid development ever 
since, boosted a deeper understanding of brain func-
tion in states of unconsciousness [1, 2]. Here we aim at 
providing an updated overview of the application and 
contribution of neuroimaging and electrophysiological 
techniques for the assessment of patients with DOC. 
Such technology-based approach seems to be impera-
tive for diagnosing these patients, especially when one 
considers that standard neurological and behavioral as-
sessment is not always accurate [3]. We will discuss the 
information we obtain about the brain’s metabolic ca-
pacities (with positron emission tomography – PET), its 
hemodynamic function (with functional magnetic reso-
nance imaging – fMRI), the metabolic and biochemical 
activity (with MRI spectroscopy), its structural proper-
ties (with diffusion weighted MRI), and the dynamics 
of cortical excitability (with electroencephalography 
recordings of transcranial magnetic stimulation evoked 
pulses – EEG/TMS). To our mind, by combining the 
temporal and spatial properties which characterize 
these different techniques, one gains a holistic vision of 
the underlying pathophysiology of patients with DOCs 
in general and of the single patient under care in par-
ticular.
tHE CLInICAL EntItIES of ConSCIouSnESS
What differentiates DOC from other states of uncon-
sciousness, such as due to pharmacological anesthesia, 
sleep and epileptic seizures, is the prolonged impaired 
awareness following severe brain damage. After an 
acute brain insult, a patient may spend some time in 
coma. Patients in coma are not awake, as evinced by 
eye closure even when intensively stimulated [4] and 
presumably they are not aware of themselves and their 
environment. Coma may arise after structural or meta-
bolic lesions of the brainstem reticular system or after 
widespread bilateral cerebral damage [4]. The condi-
tion of coma usually does not last longer than 4 weeks, 
after which patients either evolve to brain death (i.e., 
permanent loss of brainstem functions) or may com-
pletely recover consciousness or evolve to a vegetative 
state (VS) [5]. 


















The VS, recently termed as “unresponsive wakeful-
ness syndrome” (UWS; [6]), is a condition of wakeful-
ness without awareness [7]. This means that patients in 
VS/UWS open their eyes but they exhibit only reflex be-
haviors [8]. Therefore, they are considered unaware of 
themselves and their surroundings. Neuropathological 
findings seem to associate this condition to profound 
damage to the subcortical white matter and the major 
relay nuclei of the thalamus [9]. It has been further 
shown, in a large post-mortem series of patients who 
sustained a blunt traumatic brain injury, that clinical 
prognosis seems to be related to the location and extent 
of brainstem damage. Patients with lesions in central 
parts of the rostral brainstem, frequently associated 
with extensive diffusion axonal injury (DAI), showed 
no recovery from coma or VS/UWS, which occurred 
only in the patients with damage to the dorso-lateral 
brainstem tegmentum or pontine basis [10]. It has 
been proposed that the VS/UWS is permanent after 12 
months following traumatic brain injury and 3 months 
following non-traumatic insults, and therefore chances 
for recovery are slim [11]. However, patients with late 
spontaneous recoveries challenge these proposed time 
boundaries and as such the futile connotation of the 
vegetative state has been revisited [6]. Patients from 
VS/UWS may die or evolve into a minimally conscious 
state (MCS), which may be the endpoint of their im-
provement or a temporary stage on the way to further 
recovery of consciousness [12]. 
Patients is MCS exhibit sings of discernible non-re-
flex behaviors which occur reproducibly (yet inconsist-
ently) as a response to visual, auditory, tactile, or nox-
ious stimuli [12]. However, patients in MCS are not 
able to communicate accurately with their environment 
although some may show intentional sings of communi-
cation [13]. The heterogeneity of MCS has been recog-
nized and recently it has been proposed to subcatego-
rize this entity into MCS PLUS and MINUS [14]. The 
differentiation was based on the level of complexity of 
the observed behavioral responses, such as the ability to 
following simple commands [15]. Patients from MCS 
may die, regress back to VS/UWS, or emerge out of 
EMCS once they regain the ability to reliably commu-
nicate and/or use objects in a functional manner [12]. 
The temporal limits of irreversibility have not been pro-
posed yet for MCS. Although there is some evidence 
suggesting that patients in a MCS have better chances 
of recovery than patients in VS/UWS, at present we are 
not in a position to refer to possibly chronic MCS [16]. 
Some patients, most frequently after a focal brainstem 
lesion, may evolve from a coma to a locked-in syndrome 
(LIS). This is not classically a DOC, but it is worth to 
be mentioned here as it often can be misdiagnosed as a 
DOC. In classic cases, patients in LIS have a fully recov-
ered consciousness but have lost voluntary motor con-
trol, except for small eye movements making it possible 
for them to answer yes-no questions. More rarely they 
loose the control of all their voluntary muscles, includ-
ing extrinsic eyes muscles (complete LIS), making more 
challenging or impossible to communicate with them 
[17]. In these patients, the only evidence for preserved 
consciousness may be their ability to communicate via 
assisting technologies (i.e., fMRI, EEG or evoked po-
tentials). As such, the term “functional LIS” has been 
recently proposed to describe those patients with a dis-
sociation between extreme behavioral motor impairment 
and the identified preserved higher cognitive abilities 
only detectable by functional imaging techniques [14].
Differential diagnosis of the above mentioned clinical 
DOC entities raises important ethical and medical is-
sues, including end-of-life decision and pain treatment 
[18]. Nowadays, the gold standard to assess the level of 
consciousness is the clinical assessment, based on pa-
tients’ behavioral responsiveness. Because responsive-
ness represents only an indirect evidence of conscious-
ness (i.e. the lack of responsiveness does not necessarily 
imply lack of consciousness) reliance on these behavio-
ral markers presents significant challenges and may lead 
to misdiagnoses. Clinical studies have shown that up to 
40% of patients with a diagnosis of VS/UWS may in fact 
retain some level of awareness [3, 19, 20], and the main 
causes of misdiagnosis are associated with patient’s dis-
abilities, such as paralysis and aphasia, fluctuation in 
arousal level, difficulty differentiating between reflexive 
and voluntary movements, the presence of drugs’ side 
effects and the non-use of standardized and sensitive 
clinical scales such as the Coma Recovery Scale-Re-
vised (CRS-R) [13]. Furthermore, conventional brain 
structural imaging studies have shown highly variable 
and heterogeneous results in patients with DOC, sug-
gesting that a specific brain region cannot be unequivo-
cally related to awareness [21]. This knowledge has lead 
to the search for other non-clinical assessment tech-
niques in order to better understand brain function in 
these patients and to overcome the limits of behavioral 
assessment in the detection of possible retained con-
sciousness in unresponsive patients.
Positron emission tomography 
(PET)
Positron emission tomography (PET) is a nuclear 
medical imaging technique for assessing brain activity 
and function by recording the emission of positrons 
from radioactively labeled molecules. If the chosen mol-
ecule is  fludeoxyglucose (FDG), an analogue of  glu-
cose, the concentrations of tracer imaged will indicate 
tissue metabolic activity by virtue of the regional glu-
cose uptake and hence neural activity whereas the O 
labelled water PET, due to the short half-life of this mol-
ecule, is usually used to detect activation during active 
and passive paradigms [22].
When PET is used to investigate brain death, the 
so-called “hollow skull sign” is present, accounting for 
the absence of glucose uptake in the brain and there-
fore metabolic activity. In these cases the only region 
showing an uptake of glucose is the skin surrounding 
the skull [4]. In comatose patients, PET studies showed 
on average a reduced grey-matter metabolism up to 
50-70% of normal range in patients of traumatic or hy-
poxic origin [4]. After recovery from post-anoxic coma, 
cerebral metabolic rates for glucose show no drastic in-
crease, exhibiting glucose rates only up to 75% of the 
normal values [23]. Global cerebral metabolism was 
shown to correlate poorly with the level of conscious-


















ness, as measured by the Glasgow Coma Scale, in pa-
tients studied within the first month after head trauma 
[24]. Furthermore, no established relation between 
cerebral metabolic rates of glucose or oxygen as meas-
ured by PET and patient outcome has been found. A 
global decrease in cerebral metabolism, in fact, is not 
unique to coma, as it can be associated to several differ-
ent situations with temporary loss of consciousness, such 
as deep sleep [25], general anesthesia [26] and Cotard’s 
syndrome [27]. 
In VS/UWS, where awareness is impaired whilst 
wakefulness is spared, PET studies showed that unre-
sponsive patients are characterized by reduced global 
metabolism compared with healthy subjects (Figure 
1). Interestingly, recovery of consciousness from VS/
UWS does not necessarily coincide with resumption of 
global metabolic activity [17]. PET voxel-based studies 
have indicated that impairment of awareness is related 
to impairments in specific brain areas, consisting of a 
large-scale fronto-parietal network encompassing the 
polymodal associative cortices [28]. The higher-order 
associative fronto-parietal network mentioned above has 
been recently functionally subdivided into two differ-
ent networks: extrinsic awareness network and intrinsic 
awareness network [29]. The extrinsic awareness net-
work (also known as executive control network – ECN) 
encompasses the lateral fronto-parietal brain regions 
and it is related to the sensory awareness or aware-
ness of the environment. The intrinsic awareness net-
work (most widely known as the default mode network 
- DMN), encompasses mainly the medial prefrontal 
cortex, the precuneus and the bilateral posterior pari-
etal cortex, and it is related to awareness of self and 
self-related processes, such as mind-wandering and au-
tobiographical thinking [30]. Patients in VS/UWS have 
shown metabolic impairment of both the internal and 
external awareness networks [31], and to their connec-
tions with thalamic nuclei. This latter evidence stems 
from the recovery of this thalamo-cortical activity in a 
VS/UWS patient who had subsequentially recovered 
consciousness [32]. PET studies using passive auditory 
and noxious stimulation [33, 34] have furthermore dem-
onstrated a peculiar disconnection in VS/UWS patients 
between the primary sensory areas and these large-scale 
associative fronto-parietal cortices, which are thought 
to be required for conscious perception [7]. In contrast, 
function in known arousal structures including the re-
ticular formation in the brainstem, the hypothalamus, 
and the basal forebrain appeared to remain relatively 
intact [4]. In line with their clinical condition, patients 
in MCS show a partial preservation of this large-scale 
associative fronto-parietal network [35]. In particular, 
it has been demonstrated recently that MCS patients 
show a better preservation of the external awareness 
network rather than internal awareness network, which 
could suggest an impairment of self-awareness other-
wise difficult to detect at the bedside [31]. In contrast 
to VS/UWS, PET studies employing passive stimula-
tions have further confirmed a partial preservation of 
the associative fronto-parietal cortices thought to be 
required for conscious perception. More interestingly, 
PET studies employing passive noxious stimuli, have 
elicited the activation of association areas related to 
pain processing in MCS patients in a similar network 
as in normal controls, suggesting therefore a potential 
pain perception capacity in this patient category [22]. 
This information supported the idea that MCS patients 
might need analgesic treatment and has further led to 
the validation of the Nociception Coma Scale, which 
assesses behavioral responses to nocistimulation in pa-
tients surviving coma [36].
In terms of diagnostic accuracy, cerebral metabolic 
information obtained by PET has shown to be able to 
specifically and reliably differentiate VS/UWS from LIS 
Figure 1
Global brain metabolism detected by FDG-PET in a healthy control (left) and in a patient in an unresponsive wakefulness syn-
drome (right). Red colorscale indicates regions with high consumption of glucose; blue colorscale indicates regions with low 
consumption of glucose.


















patients and healthy controls [37]. It was based on PET 
investigation of brain function in MCS that the subcat-
egorization into MCS PLUS and MCS MINUS was 
suggested. In particular, patients in MCS PLUS exhib-
ited preserved metabolism in language comprehension 
related area, which is in accordance with their capaci-
ties to follow simple commands and/or communicate 
intentionally [15].
Functional magnetic resonance imaging 
(fMRI)
Functional magnetic resonance imaging (fMRI) re-
lies on the natural diamagnetic properties of oxygen-
ated hemoglobin and paramagnetic properties of des-
oxygenated  hemoglobin  to analyze changes of blood 
oxygenation in the brain associated with neural activity 
(blood oxygenated level dependent –BOLD- signal). 
As it does not require the use of X-rays and radiotrac-
ers injection, and for its superior spatial and temporal 
resolution in comparison to PET, it has been increas-
ingly used for detecting brain activity changes. In the 
last decade, fMRI has been largely used in patients with 
DOC in order to detect brain activity related to residual 
cognition and awareness, and in some cases even estab-
lished two-way communication, without requiring any 
behavioral output from patients [38]. For instance, a 
recent fMRI study using mental imagery tasks (imag-
ining playing tennis vs. spatial navigation around one’s 
house) showed that in a large cohort of 54 patients 
with DOC, five (3 patients in VS/UWS and 2 patients 
in MCS- two of them who did not show any signs of 
consciousness at behavioral assessment) were able to 
willfully modulate their brain activity; furthermore, one 
behaviorally patient in VS/UWS was able to use this 
technique to correctly respond with yes (by imagining 
playing tennis) or no (by imagining visiting the rooms 
of his house) to autobiographical questions during the 
fMRI scanning. This study showed that 17% of patients 
diagnosed as in VS/UWS after behavioral assessment 
can follow commands when such commands need a 
change in blood oxygenation level dependent response, 
rather than overt motoric behavior. Similarly, a further 
study using selective auditory attention showed that 3 
behaviorally unresponsive patients out of 3 (2 in MCS 
and 1 in VS/UWS) were able to convey their ability to 
follow commands, and 1 of them in VS/UWS was even 
able to use attention to correctly communicate answers 
to several binary questions [39]. This evidence shows 
how different tasks, which allow to overcome the motor 
unresponsiveness of brain injured patients by tackling 
different cognitive aspects, might detect residual covert 
awareness in this patient category. 
It is worth to stress that absent command-related 
brain activation does not allow to infer that awareness 
is not present [40]. Indeed, out of 31 patients in MCS 
described in the study by Monti et al. [38], only one was 
able to willfully modulate his brain activity. This could 
be related to several reasons. For example, a patient 
may not have understood the task instructions because 
of deafness or aphasia, or because of its fluctuating level 
of consciousness, or simply because he was not willing 
to perform the task, leading to possible false negatives 
results [41]. In this context, resting-state fMRI is a non 
invasive technique used to investigate the spontaneous 
temporal coherence in BOLD fluctuations related to the 
amount of synchronized neural activity (i.e., functional 
connectivity) existing between distinct brain locations, 
even in the absence of input or output tasks [42]. This 
technique has been increasingly used in the analysis of 
patients with DOC, mainly because it is non invasive 
and does not require any effort or feedback from the 
patient. Among the several functional networks that 
have been detected so far [43], the DMN has attracted 
most attention. As stated above, the DMN is defined as 
a set of areas, encompassing posterior-cingulate/precu-
neus, anterior cingulate/mesiofrontal cortex, temporo-
parietal junctions and hippocampi [5], that show more 
activity at rest than during attention-demanding tasks. 
Because of its link to internally-oriented cognitive con-
tent, DMN has been thought to be implicated in con-
sciousness processes [30, 44, 45]. Across the groups of 
patients in coma, VS/UWS, MCS, it was shown that 
DMN areas exhibited reduced functional connectiv-
ity which was correlated to the degree of conscious-
ness [46]. Recently, more networks at resting state 
have been investigated in DOC, such as the bilateral 
fronto-parietal or executive control networks, salience, 
sensorimotor, auditory, visual systems, and the cerebel-
lar network. It was found that the DMN, the bilateral 
executive control networks and the auditory system 
were significantly less identifiable (in terms of spatial 
and neural properties) in patients with DOC compared 
to healthy controls and showed consciousness-level de-
pendent decreases in functional connectivity across the 
spectrum of DOC (Figure 2). Eventually, with machine 
learning classification trained on the identification of 
these ten networks as neuronal or not, it was able to 
accurately separate healthy controls from patients in 
DOC with 85% accuracy [47]. The potential prognostic 
value of DMN connectivity was shown in a cohort of 
patients in the acute stage of coma for whom the pres-
ence of DMN functional connectivity was paralleled to 
subsequent reversibility of coma [48]. 
Decreased DMN connectivity, however, is not unique 
to DOC, as it can be associated to several different con-
ditions such as other physiological and pharmacologi-
cal loss of consciousness (sleep and general anesthesia 
[49]) and pathological conditions such as Alzheimer 
Disease [50] and drug related states such as alcohol 
[51] and amphetamine [52]. Nevertheless, the persis-
tence of coherent DMN connectivity in some patients 
in VS/UWS as well as in a known case of anesthetized 
monkey [53], in contrast with its complete absence in 
case of brain death [54], suggests that further phenom-
ena may modulate the interplay between consciousness 
and the DMN. Concurrently with decreased DMN 
connectivity, we recently reported paradoxical hyper-
connectivity in limbic structures in DOC patients (11 
VS/UWS and 7 MCS patients) compared to healthy 
controls, and more strongly in VS/UWS than in MCS 
patients [55]. This hyperconnectivity may represent an 
epiphenomenon of global decrease in neural projec-
tions in patients, indicating more resistant connection 
between DMN and limbic structures. Alternatively, it 


















may reflect the persistent engagement of residual neu-
ral activity in self-reinforcing neural loops which may 
disrupt normal patterns of connectivity [55]. This com-
plex picture is in line with previous theories explaining 
diffuse (extralimbic) connectivity reduction in patients 
with DOC, and might delineate a condition in which 
dysfunctional hyperconnectivity may impair awareness 
by permanently engaging critical neural resources. This 
scenario would suggest a much more complex and mul-
tifaceted brain connectivity architecture in DOC pa-
tients than previously thought. This being also recently 
supported by the detection of hyperconnectivity pat-
terns also in states of pharmacological coma, such as 
general anesthesia [56].
Along with intra- and inter-network connectivity, the 
importance of anti-correlation among different net-
works has further attracted scientific attention. There 
is now increasing evidence that the DMN network, or 
internal awareness network, and the executive control 
network, or external awareness network, show routinely 
an anti-correlation, i.e. when one is active the other is 
not and vice-versa. [30]. A decreased anti-correlation 
of these two networks in shown in unconscious states, 
such as anesthesia [57], deep sleep [58] and VS/UWS 
patients [54]. These findings highlight, at least partially, 
that the anti-correlated pattern between DMN and the 
executive control network may be of functional signifi-
cance to conscious cognition of subjectivity [59]. 
However, the study of resting state activity in DOC 
can be challenging to both clinical and methodologi-
cal issues. For example, patients that show pre-scan 
motion activity might need to be anesthetized during 
the scan in order to reduce the motion artifacts. In this 
case, the effect of anesthesia will need to be accounted 
during the processing of the acquired data. An example 
of a methodological problem is the spatial normaliza-
tion of these often severely severely deformed brains. 
This issue has been partially tackled in previous stud-
ies, where a mid-template [55] or study-template [37] 
was generated by taking into account the mean size of 
the group of patients and healthy controls, in order to 
use the same level of deformation in both patients and 
controls’ groups. Finally, identified resting state con-
nectivity patterns need to be interpreted according to 
the studied population. The future challenges will be 
to interpret resting-state patterns according to studied 
population, for example, in order to unravel the rela-
tionship (correlation and anti-correlation) between the 
resting state networks in different level of conscious-
ness, and to better comprehend its functional and 
clinical meaning in general and at single subject level. 
A further challenge will be to move from static func-
tional connectivity measurements to the assessment of 
temporal dynamics of connectivity, namely looking at 
the changes of correlation and anti-correlation among 
networks across time. This becomes imperative when 
considering the dynamic nature of intrinsic connectiv-
ity, which characterizes most areas of the brain beyond 
the DMN [49].
However, in practice fMRI is not suitable for all pa-
tients because it requires placing the subject into an 
MRI scanner. Therefore, its use is virtually impossible 
for those patients carrying non-compatible MRI devices 
(pace-makers, metallic implants etc), often present in 
an intensive care setting. Similarly, fMRI is not suited 
for patients at home as a “communication device”. In 
such cases, the use of electrophysiological recordings is 
more practical and appropriate.
Electroencephalography and transcranial magnetic 
stimulation (combined with electroencephalography)
Like fMRI, electroencephalography (EEG) record-
ings in patients with DOC can evaluate different as-
pects of cognitive residual function and provide means 
Figure 2
fMRI resting state connectivity in long-range (i.e., default mode network, right and left executive control) and sensory cortical 
networks (i.e., auditory) is disrupted in patients with disorders of consciousness (blue areas) compared to healthy controls (in red). 
Images are shown on triplanar anatomical slices.


















to communicate with the outside world without motor 
output. Standard recordings in the neurological depart-
ment offer a first global view of the electrogenesis of 
a patient and can detect abnormal activity and there-
fore guide treatment [60]. In resting conditions, various 
EEG paradigms have made an effort to differentiate be-
tween the clinical entities of patients with DOC. EEG 
is routinely used to confirm the diagnosis of brain death 
and can be of diagnostic importance in some cases of 
complete LIS patients [61]. Generally speaking, fol-
lowing a severe brain injury, whether it is of traumatic 
or anoxic origin, the EEG can be altered and display 
abnormalities. A visible main effect is a slowing of the 
brain activity proportional to the severity of the injury. 
Therefore, the predominant rhythm is no longer poste-
rior alpha (related to the awake stages in adult healthy 
adult individuals) but diffuse theta or delta (normally 
present in the slow stages of sleep in healthy adult in-
dividuals). In some cases alpha or theta activity can be 
observed, but its activity differs from a normal adult al-
pha activity [61]. 
Regarding DOC patients, measures of signal com-
plexity such as the bi-spectral index (a measure of the 
depth of anesthesia) were shown to discriminate be-
tween patients in VS/UWS and patients in MCS, at the 
group level [62]. The bi-spectral index was also posi-
tively correlated with behavioral scores of awareness at 
the time of testing and was associated with outcome at 
1-year post-trauma. 
However, at the single-subject level, establishing a 
diagnosis solely based on a single standard EEG is dif-
ficult since the patterns are not specific of the etiology 
and the same subject can have varying patterns in short 
intervals. A study based on patients in persistent VS/
UWS concluded that there was no possible diagnostic 
use of EEG due to its heterogeneous and varying as-
pects [63]. Despite the limited diagnostic role of stand-
ard EEG recordings, prognostic statements are possible 
but challenging as the same pattern can be found in 
encephalopathy of different origins. Furthermore, the 
outcome does not depend uniquely on the brain affec-
tion itself but on the overall condition of the patient. 
EEG information needs, therefore, to be backed-up by 
etiology in order to have insights on the prognosis [60].
In this context, active command mental paradigms 
combined with EEG [64-66] or electromyography [67] 
appear to be more convenient in the diagnosis of DOC. 
They have, in fact, allowed both detection of voluntary 
brain function in VS/UWS and functional communi-
cation in patients with complete LIS. A recent study 
showed that out of 16 studied patients, 3 of them who 
seemed to be entirely in VS/UWS on the basis of re-
peated specialist behavioral assessment, were found to 
be aware and capable of substantially and consistently 
modulating their EEG responses upon command [66]. 
However, as pointed out above, we cannot infer any di-
agnostic information from a negative result, as it does 
not necessarily imply the lack of consciousness. In fact, 
as mentioned earlier, patients with minimal conscious-
ness might still not be able to understand and follow 
instructions. In this context, EEG combined with TMS 
(TMS-EEG) may be especially useful to assess the level 
of consciousness in DOC patients, because it does not 
rely on a subject’s ability to process sensory stimuli, to 
understand and follow instructions, or to communicate. 
TMS-EEG allows to non-invasively stimulate a subset 
of cortical neurons, and to measure the effects pro-
duced by this perturbation in the rest of the brain [68, 
69]. For patients in VS/UWS, when stimulating a super-
ficial region of the cerebral cortex, TMS either induced 
no response or triggered a simple, local EEG response, 
indicating a breakdown of effective connectivity (i.e., 
the influence that one brain region exerts on another 
[70, 71]) similar to the one observed in deep sleep and 
anesthesia [69, 72]. In contrast, for patients in MCS, 
TMS triggered complex EEG activations that sequen-
tially involved distant cortical areas, similar to activa-
tions recorded in patients in LIS and healthy awake 
subjects. Interestingly, a patient in MCS assessed dur-
ing a period of no responsiveness still showed complex 
and widespread brain responses to TMS, even though 
no conscious behavior could be observed at the bed-
side [71]. Furthermore, an empirical measure of brain 
complexity, the perturbational complexity index (PCI), 
which gauges the amount of information contained in 
the integrated response of the thalamocortical system 
to a direct TMS perturbation, has recently been intro-
duced [68]. The PCI was tested on a large data set of 
TMS-evoked potentials recorded from healthy subjects 
during wakefulness, dreaming, non-rapid eye movement 
(NREM) sleep, and different levels of sedation induced 
by different anesthetic agents (midazolam, xenon, and 
propofol) as well as from brain-injured patients who had 
emerged from coma (overall, 208 sessions in 52 sub-
jects). Empirically, PCI showed to provide a data-driven 
metric that can discriminate level of consciousness in 
single subjects under different conditions: wakefulness; 
dreaming; the LIS; the MCS; the EMCS; intermediate 
levels of sedation; NREM sleep; midazolam-, xenon-, 
and propofol-induced loss of consciousness; and the 
VS/UWS [68]. Because this technique is handy, not in-
vasive, does not require patients’ cooperation and works 
at the single-subject level, it appears to be a promising 
tool for the diagnosis of patients with DOC [68].
StruCturAL MrI
Diffusion tensor imaging
Diffusion tensor imaging (DTI) is an extension of 
diffusion weighted imaging which is based on the prin-
ciple that water molecule movement is restricted by 
barriers to diffusion in the brain depending on tissue 
organization. The diffusion of water protons is higher 
along fiber tracts than across them in the white matter, 
which allows for directional measurement of diffusion 
and, hence, measurement of structural integrity. DTI 
differs from diffusion weighted imaging for the higher 
number of directions taken into considerations when 
studying the water flow (> 6). DTI data can be used to 
compute the fractional anisotropy as well as to track fib-
ers (Figure 3). The fractional anisotropy quantifies ani-
sotropic diffusion in the brain, which is related to the 
density, integrity, directionality and crossings of white 
matter tracts [73, 74]. DTI evaluates the architectural 
organization of white matter fibers and is a powerful 


















technique for in vivo detection of diffuse axonal injury 
after brain trauma [75]. 
One of the advantages of DTI is the possibility to 
evaluate brain trauma even in sedated patients, as its 
values are theoretically not influenced by sedatives or 
hypnotics, such as during clinical exams or fMRI stud-
ies. So far, DTI has been mostly used in the attempt to 
assess the prognosis in traumatic brain injured (TBI) 
patients. 
In TBI patients a significant negative correlation has 
been reported between fractional anisotropy in the sp-
lenium of the corpus callosum and in the internal cap-
sule and Glasgow Coma Scale (GCS [76]) score at dis-
charge [77]. A first study evaluating the combination 
of DTI and magnetic resonance spectroscopy (MRS) 
as a tool for predicting long-term outcome of traumatic 
patients, [78] showed that fractional anisotropy was sig-
nificantly lower in patients who did not recover at all 
measurement sites, except in the posterior pons. The 
prediction of non-recovery after 1 year could be cal-
culated with up to 86% sensitivity and 97% specificity 
when taking into account both DTI and MRS values. 
Non-recovery of traumatic patients was also shown to 
be correlated with decreased fractional anisotropy in 
cerebral peduncle, posterior limb of the internal cap-
sule, posterior corpus callosum, and inferior longitudi-
nal fasciculus [79]. 
Recent multicentric studies have further shown that 
white matter assessment with quantitative DTI in-
creases the accuracy of long-term outcome prediction 
compared with the available clinical/radiographic prog-
nostic score both in TBI and anoxic patients following 
cardiac arrest [80, 81] As regards diagnostic accuracy, a 
recent study used DTI to assess the neuropathology of 
25 patients in VS/UWS and MCS in vivo and to identify 
measures that could potentially distinguish the patients 
in these two groups [82]. The MCS and unresponsive 
patients differed significantly in subcortical white mat-
ter and thalamic regions, as measured by means of dif-
fusivity (MD) maps, but appeared not to differ in the 
brainstem. DTI results predicted scores on the CSG 
and successfully classified the patients in to their ap-
propriate diagnostic categories with an accuracy of 95% 
[82]. Furthermore, DTI showed to be helpful for char-
acterizing etiologic differences in patients in VS/UWS. 
While there was evidence of marked, broadly similar 
abnormalities in the supratentorial grey and white mat-
ter in a group of both traumatic and anoxic patients, 
discordant findings were found in the infratentorial 
compartment, with DTI abnormalities in the brainstem 
confined to the TBI group [83].
These studies confirm the relevance of using DTI as 
biomarker for consciousness recovery after a traumatic 
brain injury. The available data support the possible 
benefit of this biomarker for early classification of pa-
tients and suggest the possibility to provide objective 
method for classifying these patient populations and 
therefore to complement the behavioral assessment.
Magnetic resonance spectroscopy 
(MRS)
Magnetic resonance spectroscopy (MRS) is a non-
invasive method that is able to measure resonances of 
different metabolic compounds in the brain. Thereby, it 
can potentially provide useful metabolic information on 
brain damage that may not be visible on structural MR 
images [84]. Most often, proton MRS (1H-MRS) is 
used because of the abundance of protons in the human 
Figure 3
Neural tracks obtained with DTI in a healthy control (top) and a patient in MCS (bottom) confirms the structural damage which is 
evident in the temporo-parietal regions of the right hemisphere (bottom right - T1 MRI structural image). Colors indicate direction-
ality of water diffusion: red = left-right; green = anterior-posterior; blue = superior-inferior.


















body and its central nervous system. However, phosh-
porus MRS (31P-MR) is on the increase and may pro-
vide specific information on the energy metabolism, in 
particular. 1H-MRS at intermediate or long echo time 
(135-288 ms) yields excellent signal-to-noise ratio for 
the main metabolites choline (Cho), creatine (Cr), N-
acetylaspartate (NAA), and lactate (La). Cho is a meta-
bolic marker of membrane synthesis and catabolism, in 
particular. Its concentration is higher in white than in 
gray matter and increases when there is an increased 
membrane turnover or breakdown due to cell prolifera-
tion or inflammatory processes. Cr is considered as a 
marker of the aerobic energy metabolism. Under the 
assumption that it remains fairly constant across differ-
ent pathological conditions, it is widely used for calcu-
lating metabolite ratios such as NAA/Cr and Cho/Cr 
ratios. However, this assumption must clearly be chal-
lenged. Alternatively, the water resonance peak can be 
used for referencing. However, in TBI with brain atro-
phy cerebrospinal fluid contamination of the spectro-
scopically measured volume of interest will be increased 
and partial volume needs to be corrected for. This per-
tains to any of the metabolites measured in DOC. NAA 
is found in both gray and white matter in approximately 
equal quantities as a marker of neuronal density and 
viability produced in the mitochondria of the neurons 
and transported into the neuronal cytoplasm and the 
axons [21]. It is, on the other hand, also found in glial 
components of the central nervous system. La is a mark-
er of anaerobic glycolysis. Normally, La remains below 
or just around the reliable limits of detectability in the 
normal brain, which are commonly determined by the 
Cramer-Rao lower bounds of the metabolite quantifica-
tion. La may increase in the course of hypoxic, ischem-
ic or severe post-traumatic brain injuries. Most often, 
these increases will be transient but detecting them at 
the right time may be of prognostic value. These issues 
have not yet been investigated systematically.
In order to assess brain metabolism in coma survi-
vors, it is suggested that a comprehensive MRS proto-
col should include an axial chemical shift imaging (CSI) 
multivoxel spectroscopy at the level of the basal ganglia 
covering the thalamus, insula, and periventricular white 
matter for the supratentorial assessment and a single-
voxel point-resolved 1H spectroscopy (PRESS) placed 
on the posterior two-thirds of the pons for the infraten-
torial assessment [21]. Previous investigations have in-
dicated that 1H-MRS may be a valuable tool to predict 
patient outcome. In particular, NAA/Cr ratios seem to 
be correlated with recovery of TBI patients while no 
clear link with other metabolite ratios such as Cho/Cr 
has been observed [85]. Other studies demonstrated 
that metabolic changes in TBI patients are detectable 
by MRS even in the immediate days early after the 
trauma [86]. Here, NAA was found to be decreased. 
Its level was correlated with the initial GCS and the 
outcome at 3 months. Notably, NAA/Cho ratios were 
not suited to disentangle patients who regained con-
sciousness from those who did not recover [87]. Other 
investigations have pointed to a significant correlation 
between NAA/Cr ratio and outcome of TBI patients 
in the gray and white matter of occipito-parietal [88, 
89], frontalbrain areas [90], the splenium of corpus cal-
losum [91], and thalamic brain regions [92]. In addi-
tion, pontine MRS recorded in the acute phase after 
a trauma may allow to separate patients who recover 
from patients left with severe neurological impairments, 
in VS/UWS or those that actually die [93]. Three dis-
tinguishable pontine MRS profiles have been proposed 
after head trauma: 1) a normal profile (with higher peak 
of NAA than Cho and Cr); 2) the neuronal-loss profile 
with decreased NAA peaks (going down nearly to the 
level of the Cr peak); and 3) the gliosis profile with an 
increased Cho peak, no change in the Cr or NAA peak 
and the associated metabolite ratios. Overall, NAA/
Cr ratios seem to be of a better predictive value than 
NAA/Cho ratios in evaluating traumatic patients and 
its decrease appears to be a quite reliable index of un-
favorable outcome [84]. NAA does indeed decrease 
immediately after a severe brain trauma. Subsequently, 
it seems to decline to a minimum within 48 h. After 
that, NAA levels remain stable within the first month 
after the injury. Therefore, MRS assessments during the 
second or third week after TBI can be considered valid 
markers of the degree of the traumatic impact on the 
brain [94, 95]. Between 6 weeks and 1 year after the 
insult, the evolution of the NAA/Cr ratio is much more 
heterogeneous. Here, NAA levels have been shown 
to decrease or increase but partial volume corrections 
have not been consistently carried out which may be 
important to improve the sensitivity and specificity of 
the findings in this period following a TBI.
As indicated above, the use of metabolite ratios may 
be problematic insofar that their common denominator 
Cr is very likely not to be unaffected by TBI. Cr reso-
nances may be reduced in hypermetabolic and raised 
in hypometabolic states [96, 97] and this may well bias 
recordings obtained in mild-traumatic-injured patients 
[98]. Therefore, accurate MRS quantification and re-
peated longitudinal measurements will be the clue to 
improve MRS performance and our insights, which we 
can gain from this technology. Extension to 31P-MRS 
may be supplement further investigations as a biomarker 
of the altered energy metabolism associated with DOC.
ConCLuSIonS
In the last decade, we have witnessed the develop-
ment and the validation of standardized behavioral 
scales and neuroimaging/EEG techniques to bet-
ter understand the variable conditions of patients 
with   DOC. The need to objectively measure phe-
nomena associated with DOC has, in fact, boosted 
an increased use of the neuroimaging/EEG tech-
niques. Here we have reviewed the basic principles 
of how each of the different techniques (PET, FMRI, 
EEG, TMS-EEG) provides us with unique  informa-
tion about brain function in DOC patients. We have 
alerted the reader to the possible drawbacks of the sin-
gle techniques. For example, PET, which investigates 
brain metabolism based on radiotracer uptake, is not 
suitable as a functional communication device. fMRI, 
giving indirect measure of neural activity by BOLD 
measure, requires patients to be placed in an MR 
scanner, making it also not easily suited or impracti-


















cal as a communication devices, at least in broader 
application. Furthermore, activation tasks can easily 
lead to false negative results (i.e. if we get positive re-
sults we can infer about the presence of brain activity 
in patients but we can not infer much from a nega-
tive result). DTI and MRS provide indirect measures, 
respectively, of the structural integrity of WM tracts 
and of brain metabolism. EEG is a direct recording 
of neural activity, but establishing a diagnosis solely 
based on a single standard EEG is difficult since the 
patterns are not specific of the etiology. Finally, the 
statistical analysis of such data may require substan-
tial training. Data analysis is further challenged by the 
specific brain injuries and their sequelae in these par-
ticular type of patients which often suffer from pro-
found atrophy, focal brain lesions etc. Similarly, infer-
ring from group-level analysis results to a single given 
patient is not yet possible but would be what matters 
in the clinical context.  As one single technique can 
give partial information on the patient’s diagnosis and 
prognosis, we believe in the need of combining struc-
tural/functional neuroimaging and neurophysiological 
techniques in order to obtain a more holistic vision of 
the disease per se and of the single subject. We be-
lieve that in a far reach perspective a wide integration 
of the neurophysiological and neuroimaging available 
technique may drastically improve our diagnosis and 
subcategorization of DOC even at single patient level. 
Eventually, this may allow us to translate the results 
of such studies into clinical decisions relevant to the 
individual patient under our care.
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